| Literature DB >> 27398386 |
Hudu O Osue1, Helen I Inabo2, Sabo E Yakubu2, Patrick A Audu3, Musa Galadima4, Lillian E Odama5, Danjuma Musa1, Saleh A Ado2, Mohammed Mamman1.
Abstract
Baseline and impact assessment data were generated in 1994 (n = 532) and 2011 (n = 593) from 6 sentinel villages with generalized onchocerciasis. Only volunteers and a cohort (n = 445, 75%) were screened at both visits. Each village had received 11 (64.7%) annual treatments and 92.6%, range 88.7-100%, treatment compliance. Overall mean number of treatment was 2.9 ± 1.6 with a range 2.0 ± 1.2-3.3 ± 0.6. Significant decreases in skin microfilaria prevalence from 201 (38%) to 0 (0%), palpable nodule from 77 (15%) to 4 (0.7%), dermal changes from 51 (9.6%) to 2 (0.04%), optic nerve disease from 24 (4.5%) to 4 (2.0%), and onchocercal inducible ocular lesions from 31 (5.8%) to 12 (2.0%) were recorded, P < 0.05, (t-test of unpaired data). Cases of glaucoma, 8 (1.4%), and blindness, 6 (1.05%), remained unchanged. Visual acuity ≥6/24 in one or both eyes, 198 (33.45%); cataract, 169 (28.5%); pterygium 157 (26.5%); and acute senilis, 165 (27.9%), were significantly increased and positively correlated with increase in age (R (2) = 0.898 - 0.949). Dissected parous Simulium damnosum caught (n = 222) were without infective third stage larva. Active onchocerciasis transmission seems halted despite varied compliance to long-term ivermectin treatment. We recommend continued surveillance and targeted treatment of controlled and hypoendemic areas.Entities:
Year: 2013 PMID: 27398386 PMCID: PMC4890928 DOI: 10.5402/2013/960168
Source DB: PubMed Journal: ISRN Parasitol ISSN: 2314-4076
Figure 1Age class distribution of sample population.
Pretreatment village specific prevalence and intensity of O. volvulus skin microfilariae and palpable nodules.
| Village |
| Mf no. +ve (%) | Mf per snip | Nodule no. +ve (%) |
|---|---|---|---|---|
| Sabon Gantan | 96 | 50 (52.1) | 25.5 | 27 (28.1) |
| Kurmin Gwarza | 89 | 32 (36.0) | 9.8 | 13 (14.6) |
| Bomjock | 50 | 36 (72.0) | 20.4 | 11 (22.0) |
| Gidan Tama | 100 | 37 (37.0) | 15.9 | 9 (9.0) |
| Ungwar Shaho | 100 | 22 (22) | 16.1 | 7 (7.0) |
| Gantan | 96 | 24 (25.0) | 11.8 | 9 (10.4) |
|
| ||||
| Total | 531 | 201 (37.9) | 17.7 | 77 (14.5) |
Pretreatment age specific prevalence and intensity of microfilariae and palpable nodules in study population.
| Age group |
| Mfano. (%) +ve | GMb | Nodule No. (%) +ve |
|---|---|---|---|---|
| 15–19 yrs | 90 | 12 (11.1) | 1.3 | 1 (1.1) |
| 20–29 yrs | 151c | 56 (37.1) | 2.7 | 7 (6.0) |
| 30–39 yrs | 108 | 46 (45.4) | 3.8 | 13 (13.0) |
| 40–49 yrs | 67 | 33 (49.3) | 4.5 | 18 (26.9) |
| 50–59 yrs | 52 | 17 (32.7) | 2.6 | 17 (32.7) |
| ≥60 yrs | 63 | 36 (57.1) | 5.4 | 27 (42.9) |
aMf: microfilariae, bGM: geometric mean (calculated as e Σlog(count + 1)/, and cone person refused to be skin snipped.
Participants years of residences at post-treatment.
| S/no | Village | ≤10 years | ≥11 years | Sample population |
|---|---|---|---|---|
| (1) | Gantan | 10 (10.9%) | 82 (89.1%) | 92 (15.5%) |
| (2) | Sabon Gantan | 16 (11.4%) | 124 (88.6%) | 140 (23.6%) |
| (3) | Kurmin Gwaza | 4 (5.3%) | 72 (94.7%) | 76 (12.8%) |
| (4) | Bomjock | 10 (14.1%) | 61 (85.9%) | 71 (12.0%) |
| (5) | Gidan Tama | 17 (13.5%) | 109 (85.5%) | 126 (21.3%) |
| (6) | Ungwar Shaho | 10 (11.5%) | 77 (89.5%) | 87 (14.7%) |
|
| ||||
| Total | 67 (11.3%) | 525 (88.7%) | 592 (100%) | |
Eighteen years of ivermectin post-treatment coverage of the study area.
| S/No. | Study area | Population treatment coverage (%) | Total village treatment doses | Mean dose |
|---|---|---|---|---|
| (1) | Gantan | 91.3 | 11 | 3.2 ± 2.8 |
| (2) | Sabon Gantan | 100 | 11 | 3.3 ± 0.6 |
| (3) | Kurmin Gwaza | 85.6 | 11 | 2.1 ± 1.7 |
| (4) | Bomjock | 88.7 | 8 | 2.0 ± 1.2 |
| (5) | Gidan Tama | 96 | 11 | 3.1 ± 1.7 |
| (6) | Ungwar Shaho | 94.2 | 11 | 3.4 ± 1.6 |
| (7) | Total | 92.6 | 11 | 2.9 ± 1.6 |
Figure 2Doses of ivermectin taken by participants from 1994 to 2011.
Prevalence of onchocercal related ocular clinical manifestations in study population.
| S/no. | Study area | Sample size ( | Acute senilis | Pterygium | Glaucoma | Cataract |
|---|---|---|---|---|---|---|
| (1) | Gantan | 92 | 26 (28.3%) | 38 (41.3%) | 0 | 32 (34.8%) |
| (2) | Sabon Gantan | 140 | 42 (30.0%) | 26 (18.6%) | 0 | 29 (20.7%) |
| (3) | Kurmin Gwaza | 76 | 45(59.2%) | 27 (35.5%) | 3 (3.9%) | 41 (53.9%) |
| (4) | Bomjock | 71 | 12 (16.9%) | 12 (16.9%) | 4 (5.6%) | 17 (23.9%) |
| (5) | Ungwar Tama | 126 | 20 (18.0%) | 26 (23.4%) | 0 | 25 (22.5%) |
| (6) | Ungwa Shaho | 87 | 20 (30.3%) | 28 (42.4%) | 1 (1.5%) | 25 (37.9%) |
|
| ||||||
| Total | 592 | 165 (27.9%) | 157 (26.5%) | 8 (1.4%) | 169 (28.5%) | |
Changes in skin microfilaria and clinical signs.
| S/No. | Parameter | Post-control data | Baseline data | Impact of treatment | Statistics test |
|---|---|---|---|---|---|
| (1) | Skin mf prevalence | 0 | 144 (27.0%) | −100 |
|
| (2) | Nodule positive | 4 (0.7%) | 77 (14.4%) | −95.1 | -do- |
| (3) | Pruritus (scratch marks) | 22 (3.7%) | 24 (4.5%) | −17.8 |
|
| (4) | Skin clinical manifestations | 2 (0.4%) | 51 (9.1%) | −96.2 | -do- |
| (6) | Optic nerve disease | 4 (0.7%) | 24 (4.5%) | −77.8 |
|
| (7) | Inducible eye lesions | 12 (2.0%) | 31 (5.8%) | −65.5% |
|
| (8) | Blindness (no perception of light) | 6 | 6 | 0 | Unchanged, no new case detected |
Figure 3Post-treatment village prevalence of ocular clinical manifestations and visual impairment.
Figure 4Age class prevalence of ocular manifestations
Figure 5Cases of visual acuity measured with Snellen's illiterate E-chart.